A chronic low concentration of LPAR5 may be one of the triggers for the shift of MS to its progressive form, the SPMS subtype, which does not have remitting intervals; thus, it may be a useful marker of the SPMS transition. The gene discussed is LPAR5; the disease is myeloid sarcoma.